Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Markets:
Overview
News
Currencies
International
Treasuries

Vor Biopharma Inc. - Common Stock (NQ:VOR)

25.00 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Vor Biopharma Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit
From Vor Biopharma
Via GlobeNewswire
Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference
From Vor Biopharma
Via GlobeNewswire
The Latest Analyst Ratings for Vor Biopharma
 
Via Benzinga
What 11 Analyst Ratings Have To Say About Vor Biopharma
 
Via Benzinga
8 Analysts Have This to Say About Vor Biopharma
 
Via Benzinga
Vor Biopharma: Q1 Earnings Insights
 
Via Benzinga
Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update
From Vor Biopharma
Via GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform
From Vor Biopharma
Via GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Vor Biopharma
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 647 companies set new 52-week lows. 
Via Benzinga
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday's session, 275 companies made new 52-week lows. 
Via Benzinga
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  During the Friday's sesion, 157 stocks hit new 52-week lows. 
Via Benzinga
Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update
From Vor Biopharma
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 128 companies set new 52-week lows. 
Via Benzinga
Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference
From Vor Biopharma
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 43 companies set new 52-week lows. 
Via Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients
Vor Biopharma Inc (NASDAQ: VOR) presented updated data from patients treated in the VBP101 Phase 1/2a study of trem-cel (formerly VOR33) in  
Via Benzinga
Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in the Goldman Sachs Healthcare Conference
From Vor Biopharma
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
 
Via Benzinga
Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
From Vor Biopharma
Via GlobeNewswire
Dow Rises 50 Points; Oxford Industries Shares Plunge
U.S. stocks pared some losses toward the end of trading, with the Dow Jones and S&P 500 turning higher on Friday. The Dow traded up 0.16% to 32,156.53 while the NASDAQ fell 0.16% to 11,768.17. The S&P... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.